Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Consolidated Net Profit

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹2,163 Cr₹1,911 Cr₹1,656 Cr₹1,245 Cr₹777 Cr

What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?

The latest Consolidated Net Profit ratio of TORRENT PHARMACEUTICALS is ₹2,163 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹2,163 Cr
Mar2025₹1,911 Cr
Mar2024₹1,656 Cr
Mar2023₹1,245 Cr
Mar2022₹777 Cr

How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹2,163 Cr
13.19
Mar2025 ₹1,911 Cr
15.39
Mar2024 ₹1,656 Cr
33.02
Mar2023 ₹1,245 Cr
60.22
Mar2022 ₹777 Cr -

Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹184,494.0 Cr -2.3% 0.2% 36.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics
MANKIND PHARMA ₹94,531.6 Cr -0.8% -5.4% -12.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-2.3%

0.2%

36.6%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses